Phase 1/2 Trial of Durvalumab and Lenalidomide in Patients with Cutaneous T Cell Lymphoma (CTCL): Preliminary Results of Phase I Results and Correlative Studies

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共2页
• 作者

  Querfeld Christiane; Zain Jasmine M.; Wakefield Devin L.; Jovanovic-Talisman Tijana; Kil Sung Hee; Estephan Renee; Sanchez James; Palmer Joycelynne; Rosen Steven T.;

  展开▼
• 作者单位

  City Hope Natl Med Ctr Div Dermatol Duarte CA USA;

  City Hope Natl Med Ctr Dept Hematol Hematopoiet Cell Transplan Duarte CA USA;

  City Hope Natl Med Ctr Dept Mol Med Duarte CA USA;

  City Hope Natl Med Ctr Dept Mol Med Duarte CA USA;

  City Hope Natl Med Ctr Toni Stephenson Lymphoma Ctr Beckman Res Inst Duarte CA USA;

  City Hope Natl Med Ctr Toni Stephenson Lymphoma Ctr Beckman Res Inst Duarte CA USA;

  City Hope Natl Med Ctr Beckman Res Inst Duarte CA USA;

  City Hope Natl Med Ctr Dept Informat Sci BRI Duarte CA USA;

  City Hope Natl Med Ctr Dept Hematol Hematopoiet Cell Transplan Duarte CA USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词